Pull to refresh
Logo
Daily Brief
Following Why Ranks Sign Up
JC

Jasmine Cui

Co-founder, Chairwoman and CEO of InnoCare Pharma

Appears in 1 story

Notable Quotes

"We are happy to see that soficitinib has met the primary endpoint in the Phase III studies in atopic dermatitis with excellent clinical results."

Stories

InnoCare's oral eczema pill soficitinib clears late-stage trial

New Capabilities

Leading InnoCare toward a regulatory filing for soficitinib

Millions of people with severe eczema live with relentless itching and raw, inflamed skin. On July 15, 2026, InnoCare Pharma said its once-daily pill, soficitinib, hit the main goal of a late-stage trial in that group.

Updated Yesterday